Correlation Between Adicet Bio and Cullinan Oncology

Can any of the company-specific risk be diversified away by investing in both Adicet Bio and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adicet Bio and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adicet Bio and Cullinan Oncology LLC, you can compare the effects of market volatilities on Adicet Bio and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adicet Bio with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adicet Bio and Cullinan Oncology.

Diversification Opportunities for Adicet Bio and Cullinan Oncology

-0.37

Correlation Coefficient

Adicet Bio  Cullinan Oncology

Very good diversification

The 3 months correlation between Adicet and Cullinan is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Adicet Bio and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Adicet Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adicet Bio are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Adicet Bio i.e., Adicet Bio and Cullinan Oncology go up and down completely randomly.

Pair Corralation between Adicet Bio and Cullinan Oncology

Given the investment horizon of 90 days Adicet Bio is expected to under-perform the Cullinan Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Adicet Bio is 1.69 times less risky than Cullinan Oncology. The stock trades about -0.36 of its potential returns per unit of risk. The Cullinan Oncology LLC is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  1,720  in Cullinan Oncology LLC on February 3, 2024 and sell it today you would earn a total of  1,115  from holding Cullinan Oncology LLC or generate 64.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.65%
Values	Daily Returns

Adicet Bio  vs.  Cullinan Oncology LLC

Adicet Bio

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Adicet Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in June 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cullinan Oncology LLC

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cullinan Oncology LLC are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain technical and fundamental indicators, Cullinan Oncology displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Adicet Bio and Cullinan Oncology

The main advantage of trading using opposite Adicet Bio and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adicet Bio position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.

The idea behind Adicet Bio and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.